Nonprofit · EIN 95-4418411
PROSTATE CANCER FOUNDATION
Also known as CAP CURE
Tax-exempt · SANTA MONICA, CA 90401
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $56,686,215 | $58,177,919 | -$1,491,704 | $105,767,424 | $59,314,107 | $46,453,317 |
| December 31, 2023 | 990 | $57,291,095 | $55,134,763 | $2,156,332 | $91,770,978 | $43,788,553 | $47,982,425 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $54,024,868
- Program service revenue
- $2,687
- Investment income
- $2,658,660
- Net gain from sales of assets
- -$1,204
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $34,297,889
- Compensation of officers, directors and key employees
- $3,198,931
- Other salaries and wages
- $5,649,915
- Salaries, compensation and benefits (total)
- $10,350,813
- Professional fundraising fees
- $13,314
- Legal fees
- $58,952
- Accounting fees
- $68,631
- Occupancy
- $528,732
- Travel
- $270,984
- Depreciation
- $505,658
- Program services (functional)
- $50,048,339
- Management and general (functional)
- $4,736,021
- Fundraising (functional)
- $3,393,559
Balance sheet and other
- Total assets, start of year
- $91,770,978
- Total assets, end of year
- $105,767,424
- Total liabilities, end of year
- $59,314,107
- Net assets, end of year
- $46,453,317
- Land, buildings and equipment
- $338,794
- Net assets without donor restrictions
- $43,763,317
- Net assets with donor restrictions
- $2,690,000
- Gross receipts
- $57,665,336
- Employees
- 49
- Volunteers
- 31
- Year formed
- 1993
- State of legal domicile
- CA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| CHARLES RYAN | CEO (DEPARTED 2/2024) Officer | 60 | $961,414 | $19,569 |
| GINA CARITHERS | PRESIDENT & CEO Officer | 50 | $640,810 | $13,800 |
| HOWARD SOULE | EVP, CHIEF SCIENCE OFFICER Officer | 50 | $581,029 | $56,136 |
| HELEN HSIEH | EVP, FINANCE, CAO Key employee | 50 | $390,901 | $55,487 |
| JANET HABER | VP, EVENTS Highest-paid employee | 50 | $263,482 | $22,400 |
| CHRISTOPHER CONWAY | VP, SPORTS Highest-paid employee | 50 | $243,079 | $17,761 |
| GEORGE CHONG | CONTROLLER Highest-paid employee | 50 | $228,630 | $31,565 |
| ANDREA MIYAHIRA | SENIOR DIRECTOR, SCIENCE Highest-paid employee | 50 | $198,756 | $49,256 |
| ASHLEY HUNTER | SENIOR DIRECTOR, MARKETING Highest-paid employee | 50 | $186,314 | $42,659 |
| STUART HOLDEN MD | DIRECTOR/MEDICAL DIRECTOR Trustee or director | 30 | $225,000 | $0 |
| WILLIAM OH LEFT 42024 | EVP, CHIEF MEDICAL OFFICER Key employee | 50 | $185,984 | $26,801 |
| THE REVEREND ROSEY GRIER | DIRECTOR Trustee or director | 10 | $42,000 | $0 |
| MICHAEL MILKEN | FOUNDER & CHAIRMAN Trustee or director, Officer | 15 | $0 | $0 |
| LORI MILKEN | DIRECTOR/VP Trustee or director, Officer | 2 | $0 | $0 |
| RALPH FINERMAN | CFO, TREASURER, SECRETARY Officer | 10 | $0 | $0 |
30 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| KELVIN A BAGGET | DIR; SR MANAGING DIR, PATIENT SQUARE CAPITAL Trustee or director | 2 | $0 |
| EMILIO BASSINI | DIRECTOR Trustee or director | 2 | $0 |
| PATRICIA BERNS | DIRECTOR Trustee or director | 2 | $0 |
| GREGORY BROWN | DIRECTOR Trustee or director | 2 | $0 |
| STEVEN A BURD | DIRECTOR Trustee or director | 2 | $0 |
| JOSH COHEN | DIRECTOR Trustee or director | 2 | $0 |
| NEIL P DEFEO | DIRECTOR Trustee or director | 2 | $0 |
| DAVID A EDERER | DIRECTOR Trustee or director | 2 | $0 |
| HELMY ELTOUKHY | DIRECTOR Trustee or director | 2 | $0 |
| JONATHAN P EVANS | DIRECTOR Trustee or director | 2 | $0 |
| R CHRISTIAN B EVENSEN | DIRECTOR Trustee or director | 2 | $0 |
| PETER T GRAUER | DIRECTOR Trustee or director | 2 | $0 |
| STEIN ERIK HAGEN RETIRED 52024 | DIRECTOR Trustee or director | 2 | $0 |
| PHILIP KANTOFF MD | DIRECTOR Trustee or director | 2 | $0 |
| FREDA LEWIS-HALL MD | DIRECTOR Trustee or director | 2 | $0 |
| THE HONORABLE EARLE I MACK | DIRECTOR Trustee or director | 2 | $0 |
| SHMUEL MEITAR | DIRECTOR Trustee or director | 2 | $0 |
| MICHAEL MULDOWNEY | DIRECTOR Trustee or director | 2 | $0 |
| HENRY L NORDHOFF | DIRECTOR Trustee or director | 2 | $0 |
| DAVID DREW PINSKY | DIRECTOR Trustee or director | 2 | $0 |
| NEAL I RODIN | DIRECTOR Trustee or director | 2 | $0 |
| JASON J SAFRIET | DIRECTOR Trustee or director | 2 | $0 |
| RICHARD V SANDLER | DIRECTOR Trustee or director | 2 | $0 |
| JONATHAN W SIMONS MD | DIRECTOR Trustee or director | 2 | $0 |
| KEITH SHOATES | DIRECTOR Trustee or director | 2 | $0 |
| HOWARD SHORE | DIRECTOR Trustee or director | 2 | $0 |
| DAVID TAGLIGHT | DIRECTOR Trustee or director | 2 | $0 |
| VINCENT J VIOLA | DIRECTOR Trustee or director | 2 | $0 |
| KNEELAND YOUNGBLOOD MD | DIRECTOR Trustee or director | 2 | $0 |
| JEFF ZISK | DIRECTOR Trustee or director | 2 | $0 |
990 for the year ended December 31, 2023: 46 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| CHARLES RYAN | CEO Officer | 60 | $721,046 | $71,367 |
| HOWARD SOULE | EVP, CHIEF SCIENCE OFFICER Officer | 50 | $582,696 | $61,498 |
| GINA CARITHERS | EVP, PRESIDENT Trustee or director, Officer | 50 | $624,635 | $18,245 |
| WILLIAM OH | EVP, CHIEF MEDICAL OFFICER Key employee | 50 | $551,617 | $71,938 |
| HELEN HSIEH | EVP, FINANCE Key employee | 50 | $359,883 | $55,791 |
| MELANIE RANEN | VP, DEVELOPMENT Highest-paid employee | 50 | $250,186 | $63,668 |
| KARI J KALSTAD | VP, OPERATIONS Highest-paid employee | 50 | $274,286 | $28,148 |
| JAN HABER | VP, EVENTS Highest-paid employee | 50 | $255,992 | $25,825 |
| GEORGE CHONG | CONTROLLER Highest-paid employee | 50 | $216,269 | $32,816 |
| CHRISTOPHER CONWAY | VP, SPORTS Highest-paid employee | 50 | $205,056 | $24,686 |
| STUART HOLDEN MD | DIRECTOR/MEDICAL DIRECTOR Trustee or director | 30 | $225,000 | $0 |
| THE REVEREND ROSEY GRIER | DIRECTOR Trustee or director | 10 | $42,000 | $0 |
| MICHAEL MILKEN | FOUNDER & CHAIRMAN Trustee or director, Officer | 15 | $0 | $0 |
| LORI MILKEN | DIRECTOR/VP Trustee or director, Officer | 2 | $0 | $0 |
| RALPH FINERMAN | CFO, TREASURER, SECRETARY Trustee or director, Officer | 10 | $0 | $0 |
| KELVIN A BAGGET | DIRECTOR Trustee or director | 2 | $0 | $0 |
| EMILIO BASSINI | DIRECTOR Trustee or director | 2 | $0 | $0 |
| GREGORY BROWN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| STEVEN A BURD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JOSH COHEN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| NEIL P DEFEO | DIRECTOR Trustee or director | 2 | $0 | $0 |
| DAVID A EDERER | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JONATHAN P EVANS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| R CHRISTIAN B EVENSEN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| PETER T GRAUER | DIRECTOR Trustee or director | 2 | $0 | $0 |
| STEIN ERIK HAGEN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| PHILIP KANTOFF MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| FREDA LEWIS-HALL MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| THE HONORABLE EARLE I MACK | DIRECTOR Trustee or director | 2 | $0 | $0 |
| SHMUEL MEITAR | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MICHAEL MULDOWNEY | DIRECTOR Trustee or director | 2 | $0 | $0 |
| HENRY L NORDHOFF | DIRECTOR Trustee or director | 2 | $0 | $0 |
| DAVID DREW PINSKY | DIRECTOR Trustee or director | 2 | $0 | $0 |
| NEAL I RODIN | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JASON J SAFRIET | DIRECTOR Trustee or director | 2 | $0 | $0 |
| RICHARD V SANDLER | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JONATHAN W SIMONS MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| KEITH SHOATES | DIRECTOR Trustee or director | 2 | $0 | $0 |
| HOWARD SHORE | DIRECTOR Trustee or director | 2 | $0 | $0 |
| THOMAS S SMITH JR | DIRECTOR (LEFT 04/23) Trustee or director | 2 | $0 | $0 |
| DAVID TAGLIGHT | DIRECTOR Trustee or director | 2 | $0 | $0 |
| ROXANN TAYLOR | DIRECTOR (LEFT 11/23) Trustee or director | 2 | $0 | $0 |
| JONATHAN USUKA | DIRECTOR (LEFT 12/23) Trustee or director | 2 | $0 | $0 |
| VINCENT J VIOLA | DIRECTOR Trustee or director | 2 | $0 | $0 |
| KNEELAND YOUNGBLOOD MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JEFF ZISK | DIRECTOR Trustee or director | 2 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 1250 4TH ST STE 360, SANTA MONICA, CA 90401-1444
- Principal officer (990 for 2024)
- GINA B CARITHERS, 1250 FOURTH STREET 360, SANTA MONICA, CA 904011353
- Signed the 990
- GINA B CARITHERS, PRESIDENT & CEO
- Phone
- (310) 570-4700
- Website
- WWW.PCF.ORG
- Return prepared by
- GREEN HASSON & JANKS LLP
California records
California keeps its own records of charities and corporations. Search them by EIN 95-4418411 or by the name PROSTATE CANCER FOUNDATION.
- Attorney General, Registry of Charities and Fundraisers
- Registration status and filed reports (CT-TR-1, RRF-1)
- Secretary of State, bizfile Online
- Corporation status, entity number, agent for service
- Franchise Tax Board
- Entity status letter (state tax exemption, good standing)
Mission
THE PROSTATE CANCER FOUNDATION (PCF) FUNDS THE WORLD'S MOST PROMISING RESEARCH ON THE BIOLOGY AND TREATMENT OF PROSTATE CANCER, ACCELERATING THOSE DISCOVERIES INTO THERAPIES AND STRATEGIES DESIGNED TO IMPROVE THE QUALITY OF LIFE AND OVERALL SURVIVAL OF PATIENTS. PCF IS COMMITTED TO THE MISSION OF ENDING DEATH AND SUFFERING FROM THE DISEASE.
Program accomplishments
- THE PCF RESEARCH ENTERPRISE IS A PEER-REVIEW RESEARCH FUNDING PROGRAM THAT PROVIDES FUNDING TO 2,250 SCIENTISTS CONDUCTING INNOVATIVE RESEARCH PROJECTS AT MORE THAN 245 LEADING CANCER CENTERS AND UNIVERSITIES. PRIORITY IS GIVEN TO HIGH-RISK, HIGH-RETURN PROJECTS WITH THE GREATEST POTENTIAL TO IMPROVE SURVIVAL AND THE OVERALL QUALITY OF LIFE FOR MEN WITH PROSTATE CANCER. THE CORNERSTONE OF THE PCF RESEARCH ENTERPRISE IN 2024 WAS OUR CHALLENGE AWARDS PROGRAM AND NEW TACTICAL AWARDS PROGRAM, WHICH SUPPORT CROSS-DISCIPLINARY TEAMS OF INVESTIGATORS CONDUCTING PIONEERING RESEARCH TO ADDRESS CRITICAL UNMET MEDICAL NEEDS FOR PROSTATE CANCER PATIENTS. IN 2024, PCF FUNDED 15 MULTI-YEAR TEAM RESEARCH PROJECTS THAT EACH OFFER HIGH POTENTIAL FOR IMPROVED DETECTION, ENHANCED QUALITY OF LIFE AND HIGHER SURVIVAL RATES.Expenses $27,088,259 · grants $27,088,259
- FOR MORE THAN 3 MILLION AMERICAN MEN AND THEIR FAMILIES FIGHTING PROSTATE CANCER AND MILLIONS MORE GLOBALLY, PCF SERVES AS A PRIMARY SOURCE FOR NEW STANDARD-OF-CARE AND RESEARCH INFORMATION. PCF EDUCATES THE PUBLIC ABOUT PROSTATE CANCER RISKS, SCREENING, PREVENTION, TREATMENT OPTIONS, AND SIDE EFFECTS. WE CONNECT PATIENTS, LOVED ONES, CARE PROVIDERS, AND SCIENTISTS TO CRITICAL UPDATES, THE LATEST DEVELOPMENTS, BEST PRACTICES, AND NEWS FROM THE TREATMENT PIPELINE. SINCE PCF'S INCEPTION, AND THROUGH ITS EFFORTS, PATIENTS AROUND THE WORLD ARE LIVING LONGER, SUFFERING FEWER COMPLICATIONS, AND ENJOYING BETTER QUALITY OF LIFE. PCF AIMS TO SPUR MEN AND WOMEN ALIKE TO TALK ABOUT THIS DISEASE, TO UNDERSTAND ITS URGENCY, AND TO HAVE INFORMATION-DRIVEN HOPE.Expenses $15,750,450 · revenue $2,687
- PCF CREATED THE YOUNG INVESTIGATOR AWARD PROGRAM WITH ONE GOAL: TO BUILD A GIFTED COHORT OF HUMAN CAPITAL SUPPORTING THE NEXT GENERATION OF PROSTATE CANCER RESEARCHERS. AWARDS ARE MADE TO EARLY-CAREER SCIENTISTS WORKING IN A RESEARCH ENVIRONMENT CAPABLE OF SUPPORTING HIGH-IMPACT PROSTATE CANCER RESEARCH, DRAWN FROM A VARIETY OF MEDICAL RESEARCH DISCIPLINES. IN ITS 27TH YEAR, THE PCF PROGRAM HAS AWARDED NEARLY $93 MILLION TO ADVANCE THE CAREERS OF 435 PCF YOUNG INVESTIGATORS, ENSURING A CONTINUED STREAM OF HUMAN CAPITAL INTO OUR RESEARCH COMMUNITY. THE PCF YOUNG INVESTIGATOR PROGRAM PLAYS AN INTEGRAL ROLE IN CHAMPIONING, MENTORING, AND IDENTIFYING FUTURE MEDICAL RESEARCH PROGRAM LEADERS.Expenses $6,209,630 · grants $6,209,630
- MORE THAN 12,000 MEN CARED FOR BY THE DEPARTMENT OF VETERANS AFFAIRS (VA) HOSPITALS ARE NEWLY DIAGNOSED WITH PROSTATE CANCER EACH YEAR, MAKING IT THE MOST FREQUENTLY DIAGNOSED CANCER AMONG VETERANS. THE PCF-VA PARTNERSHIP IS EXPANDING RESEARCH INTO PROSTATE CANCER PRECISION ONCOLOGY TREATMENT OPTIONS. THE COLLABORATION IS EXPANDING THE NUMBER OF PRECISION ONCOLOGY CLINICAL STUDIES CONDUCTED AT VETERANS HEALTH ADMINISTRATION HOSPITALS, ENSURING THAT ELIGIBLE VETERANS CAN ACCESS AND PARTICIPATE IN THESE STUDIES. THE VA'S PRECISION ONCOLOGY PROGRAM FOR CANCER OF THE PROSTATE (POPCAP) WAS ESTABLISHED IN PARTNERSHIP WITH THE PROSTATE CANCER FOUNDATION 2016. THE PROGRAM USES GENETIC TESTING TO FIND THE BEST POSSIBLE TREATMENTS FOR VETERANS WITH ADVANCED PROSTATE CANCER. POPCAP'S NETWORK EXTENDS ACROSS THE U.S. IT INCLUDES 21 PRECISION ONCOLOGY CENTERS OF EXCELLENCE, SUPPLEMENTED BY REGIONAL CENTERS, THAT PROVIDE CANCER CARE TO ANY VETERAN WHO DEVELOPS PROSTATE CANCER, NO MATTER WHERE HE LIVES.Expenses $1,000,000 · grants $1,000,000
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Check at the IRS |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 95-4418411
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1993
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Philanthropy, voluntarism and grantmaking foundations (T20Z)
- Assets (IRS master file)
- $112,119,968
- Income (IRS master file)
- $62,030,866
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $56,686,215 | $58,177,919 | $105,767,424 | XML |
| 990 | December 2023 | $57,291,095 | $55,134,763 | $91,770,978 | XML |
| 990 | December 2022 | $71,921,851 | $61,472,068 | $87,285,836 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 95-4418411).
Questions about PROSTATE CANCER FOUNDATION
- What is the EIN of PROSTATE CANCER FOUNDATION?
- The employer identification number (EIN) of PROSTATE CANCER FOUNDATION is 95-4418411.
- Is PROSTATE CANCER FOUNDATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1993.
- Are donations to PROSTATE CANCER FOUNDATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does PROSTATE CANCER FOUNDATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of PROSTATE CANCER FOUNDATION due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did PROSTATE CANCER FOUNDATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of PROSTATE CANCER FOUNDATION?
- The 990 for the year ended December 31, 2024 names GINA B CARITHERS.
- Who are the officers and directors of PROSTATE CANCER FOUNDATION?
- The 990 for the year ended December 31, 2024 lists 45 people; 12 received compensation from the organization, the highest $961,414 (CHARLES RYAN, CEO (DEPARTED 2/2024)).
- How much revenue does PROSTATE CANCER FOUNDATION have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $56,686,215, expenses of $58,177,919 and total assets of $105,767,424 at year end.
Other nonprofits in SANTA MONICA
- CARL AND ROBERTA DEUTSCH FOUNDATION EIN 95-4610378 · last filed 990-PF for 2024
- MICHAEL AND LORI MILKEN FAMILY FOUNDATION EIN 82-1927087 · last filed 990-PF for 2024
- FOCUSING PHILANTHROPY INC EIN 45-2405071 · last filed 990 for 2025
- DR S JEROME & JUDITH D TAMKIN FOUNDATION EIN 46-5211327 · last filed 990-PF for 2024
- LOWELL MILKEN FAMILY FOUNDATION EIN 95-4078354 · last filed 990-PF for 2025
- EDUCATION AND SCIENCE FUND INC EIN 93-4930081 · last filed 990 for 2024
- CAMBODIAN CHILDRENS FUND EIN 20-0764162 · last filed 990 for 2025
- ROBERT AND LISA MARGOLIS FAMILYFOUNDATION EIN 20-3951826 · last filed 990-PF for 2024
All nonprofits in SANTA MONICA · California · Philanthropy, voluntarism and grantmaking foundations